Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/13/2026 | Q4 | $5.6B | -- | -- | -- | -- |
| 10/24/2025 | Q3 | $5.4B | $10.4B | $0.53 | -- | -- |
| 07/25/2025 | Q2 | $5.4B | $10B | $0.40 | -- | -- |
| 05/02/2025 | Q1 | $5.1B | $9.4B | $0.39 | -- | -- |
| 02/14/2025 | Q4 | $4.7B | $9.6B | $0.39 | -- | -- |
| 10/25/2024 | Q3 | $4.7B | $9.8B | $0.36 | -- | -- |
| 06/30/2024 | Q2 | $4.3B | $9.2B | $0.34 | -- | -- |
| 04/26/2024 | Q1 | $4.2B | $8.9B | $0.26 | -- | -- |
| 02/16/2024 | Q4 | $4.1B | $8.7B | $0.34 | -- | -- |
| 10/27/2023 | Q3 | -- | $8.3B | $0.25 | -- | -- |
| 07/28/2023 | Q2 | -- | $7.7B | $0.27 | -- | -- |
| 04/28/2023 | Q1 | -- | $6.8B | $0.32 | -- | -- |
| 02/17/2023 | Q4 | -- | $5.9B | $0.31 | -- | -- |
| 10/28/2022 | Q3 | -- | $5.1B | $0.04 | -- | -- |
| 07/29/2022 | Q2 | -- | $4.9B | $0.26 | -- | -- |
| 04/29/2022 | Q1 | -- | $4.8B | $0.23 | -- | -- |
| 02/18/2022 | Q4 | -- | $4.3B | $0.11 | -- | -- |
| 10/29/2021 | Q3 | -- | $4.5B | $0.19 | -- | -- |
| 07/30/2021 | Q2 | -- | $4.4B | $0.31 | -- | -- |
| 04/29/2021 | Q1 | -- | $4.3B | $0.16 | -- | -- |
| 02/19/2021 | Q4 | -- | $4B | -$0.03 | -- | -- |
| 10/30/2020 | Q3 | -- | $4.4B | $0.01 | -- | -- |
| 07/31/2020 | Q2 | -- | $4.3B | -$0.22 | -- | -- |
| 03/31/2020 | Q1 | -- | $5.2B | $0.07 | -- | -- |
| 12/31/2019 | Q4 | -- | $6.8B | $0.32 | -- | -- |
| 09/30/2019 | Q3 | -- | $4.9B | -$0.07 | -- | -- |
| 06/30/2019 | Q2 | -- | $6.6B | $0.30 | -- | -- |
| 03/31/2019 | Q1 | -- | $5.2B | $0.16 | -- | -- |
| 12/31/2018 | Q4 | -- | $5B | $0.07 | -- | -- |
| 09/30/2018 | Q3 | -- | $5.8B | $0.10 | -- | -- |
| 06/30/2018 | Q2 | -- | $5.7B | $0.02 | -- | -- |
| 03/31/2018 | Q1 | -- | $5.7B | $0.20 | -- | -- |
| 12/31/2017 | Q4 | -- | $5.1B | -$0.14 | -- | -- |
| 09/30/2017 | Q3 | -- | $5.1B | $0.09 | -- | -- |
| 06/30/2017 | Q2 | -- | $5.7B | $0.16 | -- | -- |
| 03/31/2017 | Q1 | -- | $4.9B | $0.06 | -- | -- |
| 12/31/2016 | Q4 | -- | $5.2B | -$1.01 | -- | -- |
| 09/30/2016 | Q3 | -- | $5.4B | -$0.11 | -- | -- |
| 06/30/2016 | Q2 | -- | $5.7B | -$0.28 | -- | -- |
| 03/31/2016 | Q1 | -- | $5.6B | -$0.26 | -- | -- |
| 12/31/2015 | Q4 | -- | $5.7B | -$0.77 | -- | -- |
NatWest Group Plc reported $10.4B worth of top line sales in its most recent quarter.
NatWest Group Plc announced earnings per share of $0.53 which represents a beat of analyst forecast a -- per share.
NatWest Group Plc reported -- that represents -- per share over the last quarter.
NatWest Group Plc's earnings are forecast to grow from $1.36 per share to -- per share next year representing an increase of 5097.27%.
NatWest Group Plc's next earnings date is February 13, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.